Inactive

The National Institute on Drug Abuse (NIDA), NIDA Office of Acquisition – NCATS Section, on behalf of the National Center for Advancing Translational Sciences (NCATS), intends to negotiate and award a... The National Institute on Drug Abuse (NIDA), NIDA Office of Acquisition – NCATS Section, on behalf of the National Center for Advancing Translational Sciences (NCATS), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to Schrodinger, L.L.C., 101 SW Main Street, Ste 1300, Portland, OR 97204, for renewal of licenses for the Small Molecule Drug Discovery Suite software. The anticipated award date is January 26, 2022. See the attached combined synopsis/solicitation for full details and requirements.